Skip to main content
OpenTrials
Completed

NCT Number: NCT04124575

Prevalence of Sarcopenia in Geriatric Patients

To assess the prevalence of sarcopenia among inpatients on acute geriatrics and geriatric rehabilitation wards of a Swiss university department of geriatric medicine using the most recent diagnosis definitions from european guidelines.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sarcopenia Atrophy Muscular Atrophy Nervous System Diseases Neurologic Manifestations Neuromuscular Manifestations Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Department of Geriatric Medicine FELIX PLATTER

Basel, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients >65 years old admitted to acute geriatrics and geriatric rehabilitation at the study site

Exclusion criteria

  • Lack of informed written consent
  • Implanted defibrillation device
  • Acute Sepsis, severe volume overload or dehydration
  • Life expectancy of < 3 months according to treating physician
  • Unremovable bandages
  • Patients in isolation rooms on the ward
  • Measurement is not possible due to organizational reasons
  • Inability to follow the procedures, e.g. due to language problems, psychological disorders

Treatment and study plan

Primary outcomes

  1. Presence of Sarcopenia (yes/no)

    Time frame: Baseline

    Using EWGSOP2 cut-off points

  2. Muscle quantity, measured by Body Impedance Analysis (kg)

    Time frame: Baseline

  3. Hand Grip Strength (kPa)

    Time frame: Baseline

  4. Gait Speed (m/s)

    Time frame: Baseline

  5. Timed up and go Test (s)

    Time frame: Baseline

Secondary outcomes

  1. Mini Mental Status (Score range from 0 to 30 Points; higher scores reflect better cognitive status)

    Time frame: Baseline

  2. Nutritional risk Screening (Score range from 0 to 7 Points; higher scores reflect higher risk of malnutrition)

    Time frame: Baseline

  3. Geriatric Depression Scale short version (Score range from 0 to 6 Points; higher scores reflect higher risk of depression)

    Time frame: Baseline

  4. Functional Independence Measure at Admission (Score range from 18 to 126 Points; higher scores reflect better functionality)

    Time frame: Baseline

  5. Calf and Mid-upper arm Circumference (cm)

    Time frame: Baseline

  6. Body Mass Index (kg/m^2)

    Time frame: Baseline

    Weight and height will be combined to report Body Mass Index in kg/m^2

Sponsors and collaborators

Lead sponsor

University Department of Geriatric Medicine FELIX PLATTER

Other

Registry information

Official study title

Prevalence of Sarcopenia in Patients Admitted to a Swiss University Department of Geriatric Medicine

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Oct 11, 2019
Registry last updated
Dec 2, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.